Abstract:Hyperthyroidism is a common endocrine disease caused by excessive secretion of thyroid hormone, which leads to the increased excitability of nervous, circulatory, and digestive systems and hypermetabolism in the body. Hypermetabolism is often manifested as palpitations, sweating, increased appetite, increased defecation, and weight loss. [ 1 ] Results of a previous study revealed that the incidence of hyperthyroidism is 2.48 times higher in females than in males and increases with age, [ 2 ] particularly in premenopausal and postmenopausal women. [ 3 , 4 ] Imbalances in thyroid function may also lead to increased risks of cardiovascular diseases such as ventricular fibrillation and thrombosis, [ 5 ] and these may be accompanied by abnormal changes in bone metabolism, and changes in blood glucose, lipid, and hormone levels, [ 6 ] In addition, hyperthyroidism may be associated with an increased risk of cancer. [ 7 ] At present, antithyroid drugs are one of the main therapeutic options for the treatment of hyperthyroidism, Notably methimazole is widely favored in clinical practice due to the unique inhibitory effect on thyroid peroxidase activity, and the inhibition of free triiodothyronine (FT3) and thyroxine synthesis. [ 8 ] However, previous studies have reported serious adverse reactions caused by methimazole alone in the treatment of hyperthyroidism, resulting in disputes over whether methimazole is still suitable for clinical use alone, or in combination with other therapeutic regimens. A cliometric statistical analysis was carried out based on uncommon adverse events, such as homeostatic liver injury induced by methimazole and insulin-induced autoimmune syndrome. Results of previous studies demonstrated that the incidence of adverse events was decreased compared with methimazole alone [ 9 ] or the incidence did not increase significantly. [ 10 ] At present, methimazole combined with propranolol is commonly used in the treatment hyperthyroidism in clinical practice. Moreover, there are numerous observational studies on the efficacy and safety of treatment, glucose and lipid metabolism, bone metabolism, and hormone levels in patients with hyperthyroidism. However, evidence-based studies using meta-analysis methods to determine the differences and quality of previous studies are limited. The present study aimed to systematically evaluate the efficacy and safety of methimazole combined with propranolol in patients with hyperthyroidism, as well as the effects on heart rate, bone metabolism, and hormone levels in patients, providing a novel theoretical basis for use in clinical practice.

Exploration on the curative effect and safety of methimazole combined with levothyroxine in treatment of children with hyperthyroidism

Methimazole Plus Levothyroxine for Treating Hyperthyroidism in Children: a Systematic Review and Meta-Analysis

A prospective clinical controlled trial of curative effect and prognosis evaluation of methimazole combination with levo-thyroxine for treatment of Graves′ disease

[Observation Time for Drug Administration and Withdrawal in the Treatment of Children with Congenital Hypothyroidism].

Treatment and Follow-Up of Children with Transient Congenital Hypothyroidism.

Laboratory Characteristics Analysis of the Efficacy of Levothyroxine on Subclinical Hypothyroidism During Pregnancy: a Single-Center Retrospective Study

Evaluation of Therapy and Screening for Congenital Hypothyroidism in Neonates

Clinical analysis about 2 789cases of congenital hypothyroidism

Diagnosis and treatment of subclinical hypothyroidism detected by neonatal screening

The clinical effects of Selenious yeast tablets combined with Levothyroxine sodium in patients with hypothyroidism

Clinical effect of Yougui Pills combined with Levothyroxine Sodium Tablets in the treatment of hypothyroidism

The effects of methimazole combined with propranolol on heart rate, bone metabolism, and thyroid hormone levels in patients with hyperthyroidism: A systematic review and a meta-analysis of case–control studies

Clinical study on combined moxibustion and medication for Hashimoto’s thyroiditis

Observation on Clinical Efficacy of Thyrotoxicosis Patients Merging Atrial Fibrillation by Metoprolol Tartrate Combined with Thiamazole

Seleiium yeast cnmbiied with levnthyrnxiie tablets ii treatmeit nf Hashimntn′s thyrniditis

Clinical Observation of Levothyroxine Sodium Combined with Selenium in the Treatment of Patients with Chronic Lymphocytic Thyroiditis and Hypothyroidism and the Effects on Thyroid Function, Mood, and Inflammatory Factors

Effect of Selenium Yeast Tablets Combined with Levothyroxine Sodium on Thyroid Function and Inflammatory Factors in Patients with Hypothyroidism

The Effect of the Plasma Methotrexate Concentration During High-Dose Methotrexate Therapy in Childhood Acute Lymphoblastic Leukemia.

THERAPEUTIC EFFECTS OF COMBINATION REGIMENS INCLUDING METHIMAZOLE ON GRAVES HYPERTHYROIDISM: A NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Efficacy of selenium supplementation for patients with Graves' hyperthyroidism during methimazole treatment: protocol for a systematic review and meta-analysis

Clinical comparative efficacy and therapeutic strategies for the Hashimoto's thyroiditis: A systematic review and network meta-analysis